SLC2A1 and acute lymphoblastic leukemia: Only five metabolites were significantly altered after 4-OHT treatment of control CreERT2 B-ALL cells, whereas 43 metabolites were specifically changed in response to Glut1 deletion (Figure 2b and Supplementary Table 1).